Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Valchlor-Induced Skin Irritation
NCT02968446Phase 1Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Nov 2016
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in dermatitis comparing Placebo with Vitamin D (2 arms). Primary endpoint: Change in skin erythema at 1 week. Started Nov 2016; status: completed.
02
Drugs
vitamin d
03
Conditions
dermatitis
Beyond the preview
Go deeper on NCT02968446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02968446.